In a new study, researchers developed a three-dimensional (3D) in vitro tissue model to assess the effects of SARS-CoV-2 on the vascular endothelial cells.

“Despite the huge efforts of researchers to develop machine learning models for COVID-19 diagnosis and prognosis, we found methodological flaws and many biases throughout the literature, leading ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Israeli biopharmaceutical firm RedHill Biopharma Ltd. said Tuesday that a drug it is developing has shown to be a “potent” inhibitor of the virus that causes COVID-19 in an in-vitro model of ...

MONTREAL, Jan. 26, 2021 /CNW/ - An article titled "In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E ...

Mathematical models and computer simulations are the new frontiers in COVID-19 drug trials. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2021 / 07 / 210719103027.htm ...

Nirmatrelvir is an orally administered severe acute respiratory syndrome coronavirus 2 main protease (Mpro) inhibitor with potent pan–human-coronavirus activity in vitro. We conducted a phase 2 ...

The SEIR model is just one of several COVID-19 modelling efforts, and Lafferty is handling the day-to-day operations of the team, supporting EL Senior Research Scientist Dr. Todd Bridges, ...

Model-makers have to work with the data they have, yet a novel virus, such as the one that causes COVID-19, has a lot of unknowns. For example, the Imperial College model uses numbers from Wuhan ...